See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct.10, 2002

Diabetes Mellitus Cancer Prevention Chronic Pain

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch.

Diabetic Mellitus

Protein Kinase C beta Inhibitor - Albuminuria Study in Patients with Type 2 Diabetes Mellitus. The purpose of this trial is to determine whether the investigational drug can reduce urinary albumin/creatinine excretion in patients with Type II diabetes and persistent albuminuria, whether the investigational drug reduces urinary TGF-beta and the safety of the investigational drug and any side effects that may be associated with it. Research sites throughout the USA.

More Information

Please see http://www.centerwatch.com/patient/studies/cat55.html.

-----

Cancer Prevention

Selenium and Vitamin E Cancer Prevention Trial (SELECT). A 12-year national study designed to test the effectiveness of Selenium and Vitamin E in the prevention of prostate cancer. Research site in New York.

More Information

Please see http://www.centerwatch.com/patient/studies/cat580.html.

-----

Chronic Pain

A randomized, double-blind, placebo-controlled research study of Intrathecal Ziconotide in Adults with Severe Chronic Pain. Research sites throughout the USA.

More Information

Please see http://www.centerwatch.com/patient/studies/cat45.html.

-----

Copyright 2002 Centerwatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.